Amylin Pharmaceuticals, Inc. to Present at Jefferies and Co. 2012 Global Healthcare Conference and Goldman, Sachs & Co. 33rd Annual Global Healthcare Conference

SAN DIEGO--(BUSINESS WIRE)--Amylin Pharmaceuticals, Inc. (Nasdaq:AMLN) will be presenting at the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5 at 1:30 p.m. ET/10:30 a.m. PT in New York and at the Goldman Sachs 33rd Annual Global Healthcare Conference on Wednesday, June 6 at 2:20 p.m. ET/11:20 a.m. PT in Rancho Palos Verdes, California. Mark G. Foletta, senior vice president, finance and chief financial officer of Amylin, will provide a corporate overview at the Jeffries conference. Daniel M. Bradbury, president and chief executive officer of Amylin, will provide a corporate overview at the Goldman Sachs conference.

Back to news